" class="no-js "lang="en-US"> Harshit Shah - Medtech Alert
Saturday, September 20, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Harshit Shah

Harshit Shah

About Harshit Shah

• I have lead multi-disciplinary teams (Engineering, Product, UX, BizDev, technical marketing) to deliver on several successful products – from v1 to at scale.
• Building products that delight customers and pushing the envelop for innovations is my passion.
• Focus Areas: AWS, Azure, Cloud strategy, Productivity Apps, IoT, SaaS, Cloud Native Applications, Distributed Systems, Containers, Docker, CI/CD, Experimentation Systems, At-scale services, Web, Native and Mobile applications.

Related Story

Appointments

 Spring Health Announces Harshit Shah as New Chief Technology Officer | Pharmtech Focus

Spring Health Announces Harshit Shah as New Chief Technology Officer

June 18 2021

Spring Health, a leading provider of behavioral health benefits with the most comprehensive solution for […]